“We continue to think the rotation to value should be focused on creating a more balanced value/growth portfolio…” said Tom Essaye, editor of The Sevens Report investing newsletter, in a report Tuesday. Click here to read the full article.
Sevens Research Report Founder and President Tom Essaye interviewed with BNN Bloomberg, says the clarity in the Biden administration and on vaccine development that took place in November is giving investors…Click here to watch the full interview.
The residual rancor from the presidential election nevertheless has bled into hopes for a fourth stimulus package, according to Tom Essaye of the Sevens Report. He added that “the looming Georgia [Senate] runoffs complicate…” Click here to read the full article.
Stock investors may be in something of a “post-election fog” or a “drunken euphoria” about an apparent quick conclusion to the presidential race but may also be repricing expectations for economic growth, says Tom Essaye, director of Sevens Report Research. Click here to read the full article.
“If the race is decided by the verdict in a single state … and the margin is close (less than 1%), then both the Biden and Trump campaigns will send lawyers…” wrote Tom Essaye, president of The Sevens Report. Click here to read the full article.
“Ultimately, the markets want clarity, and the main threat to risk assets this week is the emergence of a contested election, so if races are tight enough for campaigns…” Tom Essaye, founder of The Sevens Report, wrote in a note. Click here to read the full article.
Tom Essaye, founder and president at Sevens Report Research, interviewed with BNN Bloomberg on October 10, 2020. He says the velocity with which the U.S. stock market has been…Click here to watch the full interview.
“By giving the market a lot lodging … the Fed has primarily created a spoiled youngster the place nothing’s sufficient…” Tom Essaye, founder and president of Sevens Analysis, tells Axios. Click here to read the full article.
“Some froth has come off the market which is a good thing, but keep in mind that we still remain well over levels…” Tom Essaye, a former Merrill Lynch trader who founded The Sevens Report newsletter, wrote in a note. Click here to read the full article.
“While the early use authorization for plasma is clearly a positive, from a market standpoint a vaccine remains a true…” says Tom Essaye, editor of the Sevens Report. Click here to read the full article.
